tiotropium inhalation powder capsule

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 3

A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT00239434

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2003-06-30End: 2004-03-31Target: 200Updated: 2012-05-14

Efficacy and Safety of Tiotropium and Atrovent in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02172469

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2001-05-31Updated: 2014-06-24